[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aspire Biopharma Holdings Inc (ASBP)

Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aspire Biopharma Holdings Inc 23150 Fashion Dr. Suite 232 Estero FL 33928 USA

www.aspirebiolabs.com P: 908-987-3002

Sector:

Medical

Description:

Aspire Biopharma Inc. is a privately held, early-stage biopharmaceutical technology company. It engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals and supplements. Aspire Biopharma Inc., formerly known as PowerUp Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 865
Enterprise Value, $K 2,655
Shares Outstanding, K 167
Float, K 158
% Float 94.20%
Short Interest, K 373
Short Float 7.44%
Days to Cover 1.00
Short Volume Ratio 0.59
% of Insider Shareholders 5.80%
% of Institutional Shareholders 19.17%

Financials:

Annual Sales, $ 10 K
Annual Net Income, $ -24,480 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,710 K
EBIT, $ -19,360 K
EBITDA, $ -11,340 K

Growth:

1-Year Return -98.70%
3-Year Return -99.96%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.60 on 11/14/25
Next Earnings Date 05/13/26 [--]
Earnings Per Share ttm -20.00
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 95.70%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 05/11/26

ASBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -1,468.13%
Profit Margin % -244,800.00%
Debt/Equity -0.44
Price/Sales 153.92
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.81
Interest Coverage -1.87
60-Month Beta 0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.